We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$10.3B
AUM Growth
+$817M
Cap. Flow
+$647M
Cap. Flow %
6.3%
Top 10 Hldgs %
9.34%
Holding
2,856
New
754
Increased
869
Reduced
698
Closed
531

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$113M
2
TJX icon
TJX Companies
TJX
+$95.9M
3
YUM icon
Yum! Brands
YUM
+$87.7M
4
CL icon
Colgate-Palmolive
CL
+$69.2M
5
DIS icon
Walt Disney
DIS
+$68.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.03%
2 Technology 12.14%
3 Financials 10.96%
4 Healthcare 10.46%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
2151
Aquestive Therapeutics
AQST
$462M
$160K ﹤0.01%
38,190
+22,190
+139% +$114K
NMFC icon
2152
New Mountain Finance
NMFC
$646M
$160K ﹤0.01%
+11,476
New +$160K
SBLK icon
2153
Star Bulk Carriers
SBLK
$3.14B
$160K ﹤0.01%
+16,607
New +$133K
WATT icon
2154
Energous
WATT
$80.3M
$158K ﹤0.01%
60
+7
+13% +$20.4K
HALL
2155
DELISTED
Hallmark Financial Services, Inc.
HALL
$158K ﹤0.01%
+1,112
New +$133K
BLCM
2156
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$157K ﹤0.01%
9,257
+6,958
+303% +$188K
CPRX
2157
DELISTED
Catalyst Pharmaceutical
CPRX
$156K ﹤0.01%
+40,500
New +$175K
TA
2158
DELISTED
TravelCenters of America LLC
TA
$156K ﹤0.01%
8,620
-13,816
-62% -$265K
GNCA
2159
DELISTED
Genocea Biosciences, Inc.
GNCA
$155K ﹤0.01%
39,427
+38,176
+3,052% +$199K
ULBI icon
2160
Ultralife
ULBI
$88.3M
$151K ﹤0.01%
+19,052
New +$173K
UCFC
2161
DELISTED
United Community Financial Corp
UCFC
$151K ﹤0.01%
+15,763
New +$147K
AXLA
2162
DELISTED
Axcella Health Inc. Common Stock
AXLA
$150K ﹤0.01%
+644
New +$204K
ACTG icon
2163
Acacia Research
ACTG
$450M
$149K ﹤0.01%
+50,342
New +$157K
ORBC
2164
DELISTED
ORBCOMM, Inc.
ORBC
$148K ﹤0.01%
20,400
-58,161
-74% -$414K
ARDX icon
2165
Ardelyx
ARDX
$1.24B
$146K ﹤0.01%
54,427
-213,693
-80% -$643K
OBSV
2166
DELISTED
ObsEva SA Ordinary Shares
OBSV
$146K ﹤0.01%
+12,900
New +$162K
ADAM
2167
Adamas Trust
ADAM
$777M
$145K ﹤0.01%
+5,839
New +$144K
HNRG icon
2168
Hallador Energy
HNRG
$718M
$144K ﹤0.01%
+25,539
New +$138K
STRO icon
2169
Sutro Biopharma
STRO
$379M
$142K ﹤0.01%
+1,250
New +$138K
GECC icon
2170
Great Elm Capital Corp
GECC
$72.5M
$141K ﹤0.01%
+2,703
New +$139K
KVHI icon
2171
KVH Industries
KVHI
$177M
$141K ﹤0.01%
+13,000
New +$129K
CNST
2172
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$140K ﹤0.01%
+11,400
New +$127K
AXAS
2173
DELISTED
Abraxas Petroleum Corp
AXAS
$140K ﹤0.01%
6,799
+6,193
+1,022% +$151K
NESR
2174
National Energy Services Reunited Corp
NESR
$2.79B
$139K ﹤0.01%
+16,000
New +$153K
CALA
2175
DELISTED
Calithera Biosciences, Inc
CALA
$138K ﹤0.01%
+1,765
New +$200K

Similar funds

Squarepoint's Q2 2019 Portfolio in Review

As of Q2 2019, Squarepoint held 2,856 positions worth $10.3B, up 8.7% from $9.44B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Squarepoint deployed $647M of net new capital in Q2 2019, opening 754 new positions and adding to 869 existing holdings. Its largest new stake was Celgene Corp: 988,338 shares worth $91.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Dollar General, an estimated $113M trimmed.

  • Squarepoint's largest Q2 2019 buy was Celgene Corp: 988,338 shares worth $91.4M.
  • Squarepoint added most to Amazon in Q2 2019, an estimated $97.9M increase.
  • Squarepoint's biggest Q2 2019 reduction was Dollar General, cutting an estimated $113M.
  • Squarepoint fully exited iShares MSCI India ETF in Q2 2019, selling an estimated $55.7M.
  • Squarepoint's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2019.
  • Squarepoint opened 754 new positions and closed 531 in Q2 2019.
  • Squarepoint's portfolio value rose 8.7% quarter-over-quarter to $10.3B.

Based on Squarepoint's 13F filing for Q2 2019, filed 14 Aug 2019.